ID945B - NEW CHRONICS AND ITOCROMAN'S DEMONS - Google Patents
NEW CHRONICS AND ITOCROMAN'S DEMONSInfo
- Publication number
- ID945B ID945B IDP185892A ID921858A ID945B ID 945 B ID945 B ID 945B ID P185892 A IDP185892 A ID P185892A ID 921858 A ID921858 A ID 921858A ID 945 B ID945 B ID 945B
- Authority
- ID
- Indonesia
- Prior art keywords
- itocroman
- chronics
- demons
- new
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyrane Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Threshing Machine Elements (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
- Liquid Crystal Substances (AREA)
- Harvester Elements (AREA)
- Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Medicinal Preparation (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Compounds of formula (I), processes for their preparation, pharmaceutical preparations, use of and method of treatment of disorders in CNS by using compounds of formula (I).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8904361A SE8904361D0 (en) | 1989-12-22 | 1989-12-22 | NEW CHROMAN AND THIOCHROMAN DERIVATIVES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID945B true ID945B (en) | 1996-09-20 |
Family
ID=20377869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDP185892A ID945B (en) | 1989-12-22 | 1992-01-30 | NEW CHRONICS AND ITOCROMAN'S DEMONS |
Country Status (42)
| Country | Link |
|---|---|
| EP (1) | EP0460169B1 (en) |
| JP (1) | JP2879972B2 (en) |
| KR (1) | KR0178991B1 (en) |
| CN (1) | CN1037438C (en) |
| AT (1) | ATE138918T1 (en) |
| AU (1) | AU641204B2 (en) |
| CA (1) | CA2047237C (en) |
| CY (1) | CY1991A (en) |
| CZ (1) | CZ283630B6 (en) |
| DE (1) | DE69027311T2 (en) |
| DK (1) | DK0460169T3 (en) |
| DZ (1) | DZ1469A1 (en) |
| EG (1) | EG19749A (en) |
| ES (1) | ES2087993T3 (en) |
| FI (1) | FI102177B (en) |
| GR (1) | GR3020497T3 (en) |
| HK (1) | HK55897A (en) |
| HR (1) | HRP920851B1 (en) |
| HU (1) | HU211860A9 (en) |
| ID (1) | ID945B (en) |
| IE (1) | IE80753B1 (en) |
| IL (1) | IL96712A (en) |
| IS (1) | IS1665B (en) |
| LT (1) | LT3967B (en) |
| LV (2) | LV10449B (en) |
| MX (1) | MX23889A (en) |
| NO (1) | NO180336C (en) |
| NZ (1) | NZ236407A (en) |
| PH (1) | PH30797A (en) |
| PL (3) | PL164609B1 (en) |
| PT (1) | PT96304B (en) |
| RU (1) | RU2092483C1 (en) |
| SA (1) | SA90110186B1 (en) |
| SE (1) | SE8904361D0 (en) |
| SG (1) | SG48043A1 (en) |
| SI (1) | SI9012429B (en) |
| SK (1) | SK280261B6 (en) |
| TW (1) | TW221056B (en) |
| UA (1) | UA34416C2 (en) |
| WO (1) | WO1991009853A1 (en) |
| YU (2) | YU47936B (en) |
| ZA (1) | ZA909708B (en) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5420151A (en) * | 1989-12-22 | 1995-05-30 | Aktiebolaget Astra | Chroman derivatives |
| DE69124868T2 (en) * | 1990-08-15 | 1997-07-10 | Lilly Co Eli | Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes, 3-aminochromanes and 3-aminothiochromanes |
| IL114760A (en) * | 1991-02-08 | 1997-11-20 | Lilly Co Eli | Ring-substituted-2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes intermediates thereto |
| HRP920935A2 (en) * | 1991-10-08 | 1995-08-31 | Astra Ab | New therapeutically active compound |
| SE9103745D0 (en) * | 1991-12-18 | 1991-12-18 | Wikstroem Haakan | ARYL-TRIFLATES AND RELATED COMPOUNDS |
| FR2691149B1 (en) * | 1992-05-18 | 1994-07-08 | Adir | NOVEL THIOCHROMANIC COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
| US5434174A (en) * | 1992-07-17 | 1995-07-18 | Eli Lilly And Company | Isoxazole derivatives for the treatment of irritable bowel syndrome |
| SE9301732D0 (en) * | 1993-05-18 | 1993-05-18 | Haakan Wilhelm Wikstroem | NEW CENTRALLY ACTING 5-, 6-, 7-, AND 8-SUBSTITUTED SULPHONE ESTERS OF N-MONOSUBSTITUTED 2-AMINOTETRALINS |
| SE9703377D0 (en) | 1997-09-18 | 1997-09-18 | Astra Ab | New compounds |
| SE9703378D0 (en) * | 1997-09-18 | 1997-09-18 | Astra Ab | New compounds |
| US6184226B1 (en) | 1998-08-28 | 2001-02-06 | Scios Inc. | Quinazoline derivatives as inhibitors of P-38 α |
| BR0206514A (en) * | 2001-01-16 | 2004-01-06 | Astrazeneca Ab | Compound, method of treating a human or animal suffering from migraine, use of the compound, pharmaceutical composition, and process for preparing a compound |
| BR0206513A (en) | 2001-01-16 | 2004-01-06 | Astrazeneca Ab | Composition, methods of treatment of a human or animal suffering from depression, generalized anxiety, eating disorders, dementia, panic disorder, sleep disorders, gastrointestinal disorders, motor disorders, endocrine disorders, vasospasm and sexual dysfunction, use of any of the compounds, pharmaceutical composition, and process for preparing compounds |
| IL156595A0 (en) | 2001-01-16 | 2004-01-04 | Astrazeneca Ab | Therapeutic heterocyclic compounds |
| JP5080716B2 (en) | 2001-07-20 | 2012-11-21 | サイコジェニックス・インコーポレーテッド | Treatment of attention deficit / hyperactivity disorder |
| US7125904B2 (en) | 2002-10-11 | 2006-10-24 | Portela & C.A., S.A. | Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation |
| SE0301796D0 (en) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use II |
| SE0301795D0 (en) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use I |
| US20080221193A1 (en) * | 2006-12-22 | 2008-09-11 | Wyeth | 3-amino chromane derivatives |
| SA08290245B1 (en) * | 2007-04-23 | 2012-02-12 | استرازينيكا ايه بي | Novel n- (8-Heteroaryltetrahydronaphtalene-2-Y1) or N- (5- Heteroarylchromane-3-Y1) Carboxamide Derivatives for the Treatment of Pain |
| CN101712672B (en) * | 2008-10-06 | 2013-02-06 | 中国中医科学院中药研究所 | Novel compound for treating diseases of cardiovascular and cerebrovascular systems, preparation method and application thereof |
| DE102010041948A1 (en) | 2010-10-04 | 2012-04-05 | Mahle International Gmbh | filtering device |
| GB201316410D0 (en) | 2013-09-13 | 2013-10-30 | Bial Portela & Ca Sa | Processes for preparing peripherally-selective inhibitors of dopamine-?-hydroxylase and intermediates for use therein |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH22522A (en) * | 1985-09-03 | 1988-10-17 | Ciba Geigy Ag | 3-amino-dihydro-1-benzopyrans and benzothiopyrans, their pharmaceutical compositions and method of using said compounds |
| US4801605A (en) * | 1986-08-29 | 1989-01-31 | Ciba-Geigy Corporation | 3-amino-dihydro-[1]-benzopyrans and benzothiopyrans |
| SE8605504D0 (en) * | 1986-12-19 | 1986-12-19 | Astra Laekemedel Ab | NOVEL CHROMAN DERIVATIVES |
| US5258287A (en) * | 1988-03-22 | 1993-11-02 | Genentech, Inc. | DNA encoding and methods of production of insulin-like growth factor binding protein BP53 |
-
1989
- 1989-12-22 SE SE8904361A patent/SE8904361D0/en unknown
-
1990
- 1990-12-03 ZA ZA909708A patent/ZA909708B/en unknown
- 1990-12-10 NZ NZ236407A patent/NZ236407A/en unknown
- 1990-12-11 PH PH41705A patent/PH30797A/en unknown
- 1990-12-12 DZ DZ900224A patent/DZ1469A1/en active
- 1990-12-17 IE IE453590A patent/IE80753B1/en not_active IP Right Cessation
- 1990-12-18 IL IL9671290A patent/IL96712A/en not_active IP Right Cessation
- 1990-12-19 JP JP3501912A patent/JP2879972B2/en not_active Expired - Fee Related
- 1990-12-19 IS IS3662A patent/IS1665B/en unknown
- 1990-12-19 DE DE69027311T patent/DE69027311T2/en not_active Expired - Fee Related
- 1990-12-19 EP EP91901496A patent/EP0460169B1/en not_active Expired - Lifetime
- 1990-12-19 WO PCT/SE1990/000863 patent/WO1991009853A1/en active IP Right Grant
- 1990-12-19 RU SU905001901A patent/RU2092483C1/en not_active IP Right Cessation
- 1990-12-19 SG SG1996006565A patent/SG48043A1/en unknown
- 1990-12-19 UA UA5001901A patent/UA34416C2/en unknown
- 1990-12-19 CA CA002047237A patent/CA2047237C/en not_active Expired - Fee Related
- 1990-12-19 ES ES91901496T patent/ES2087993T3/en not_active Expired - Lifetime
- 1990-12-19 DK DK91901496.9T patent/DK0460169T3/en active
- 1990-12-19 KR KR1019910700957A patent/KR0178991B1/en not_active IP Right Cessation
- 1990-12-19 AT AT91901496T patent/ATE138918T1/en not_active IP Right Cessation
- 1990-12-19 AU AU69770/91A patent/AU641204B2/en not_active Ceased
- 1990-12-20 EG EG75290A patent/EG19749A/en active
- 1990-12-20 PT PT96304A patent/PT96304B/en not_active IP Right Cessation
- 1990-12-21 PL PL90293066A patent/PL164609B1/en not_active IP Right Cessation
- 1990-12-21 PL PL90288405A patent/PL164592B1/en not_active IP Right Cessation
- 1990-12-21 SK SK6578-90A patent/SK280261B6/en unknown
- 1990-12-21 CZ CS906578A patent/CZ283630B6/en not_active IP Right Cessation
- 1990-12-21 TW TW079110767A patent/TW221056B/zh active
- 1990-12-21 SI SI9012429A patent/SI9012429B/en not_active IP Right Cessation
- 1990-12-21 PL PL90293065A patent/PL164608B1/en not_active IP Right Cessation
- 1990-12-21 MX MX2388990A patent/MX23889A/en unknown
- 1990-12-21 YU YU242990A patent/YU47936B/en unknown
- 1990-12-21 CN CN90106068A patent/CN1037438C/en not_active Expired - Fee Related
- 1990-12-22 SA SA90110186A patent/SA90110186B1/en unknown
-
1991
- 1991-04-22 YU YU72191A patent/YU47923B/en unknown
- 1991-08-21 FI FI913943A patent/FI102177B/en not_active IP Right Cessation
- 1991-08-21 NO NO913273A patent/NO180336C/en unknown
-
1992
- 1992-01-30 ID IDP185892A patent/ID945B/en unknown
- 1992-10-02 HR HRP-2429/90A patent/HRP920851B1/en not_active IP Right Cessation
-
1993
- 1993-06-30 LV LVP-93-819A patent/LV10449B/en unknown
- 1993-12-30 LT LTIP1730A patent/LT3967B/en not_active IP Right Cessation
-
1995
- 1995-06-30 HU HU95P/P00717P patent/HU211860A9/en unknown
-
1996
- 1996-07-10 GR GR960401865T patent/GR3020497T3/en unknown
-
1997
- 1997-05-01 HK HK55897A patent/HK55897A/en not_active IP Right Cessation
- 1997-06-05 LV LVP-97-111A patent/LV11894B/en unknown
- 1997-09-05 CY CY199197A patent/CY1991A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID945B (en) | NEW CHRONICS AND ITOCROMAN'S DEMONS | |
| IT9048260A0 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RESPIRATORY DISORDERS AND METHOD FOR ITS APPLICATION. | |
| DK549189D0 (en) | GALANTHAMINE ANALOGUE AND USE OF THESE FOR THE PREPARATION OF MEDICINALS FOR TREATMENT OF ALZHEIMER'S DISEASE | |
| IT9048261A0 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RESPIRATORY DISORDERS AND METHOD FOR ITS APPLICATION. | |
| IT8009551A0 (en) | E-5-(2-HALOGENOVINIL-)-2'DEOXYCYTIDINES, THEIR METHOD OF PREPARATION AND THEIR USE FOR THE TREATMENT OF VIRUS DISEASES | |
| NO972449L (en) | Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one-1,1-dioxide derivatives and preparations and process for use thereof | |
| DK0471718T3 (en) | Paracetamol-containing pharmaceutical composition | |
| DE69026511D1 (en) | USE OF GIBBERELLINES FOR PRODUCING A MEDICINAL PRODUCT FOR TREATING PROSTATITIS | |
| ATE107165T1 (en) | USE OF MACROLACTONES AS ANTIALLERGICS. | |
| SE8802323D0 (en) | 8ALFA-ACYLAMINOERGOLINE, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | |
| DE69207575D1 (en) | Process for the preparation of 2,3-dichloro-1-propanol and reactor used therefor |